- 大会
- 英卡思巴黎国际年会 - 2025年 1月
- 英卡思美洲年会 - 2025年 4月
- 英卡思亚洲年会 - 2025年 6月
- 英卡思中国大会 - 2025年 7月
- 大师精品课
- 英卡思印度大会 - 2025年 11月
- 大会
- 英卡思巴黎国际年会 - 2025年 1月
- 英卡思美洲年会 - 2025年 4月
- 英卡思亚洲年会 - 2025年 6月
- 英卡思中国大会 - 2025年 7月
- 大师精品课
- 英卡思印度大会 - 2025年 11月

英卡思学院

注册新账号

介绍
注册
大会日程
讲者
至尊晚宴
英卡思个人参会日程
递交讲稿摘要
赞助企业名单
认证
媒体与新闻

回到上页

2025 英卡思巴黎国际年会
大会日程

聚焦

Hair restoration - Contributed talks

会议室： Room 151 - Level 1
日期： 2025年 1月 30日星期四从 10:00 至 11:30
组织形式： 投稿演讲 > 基于对提交的演示文稿摘要的审核，学术委员会通过的投稿演讲。

主席

Rubina ALVES 医师

皮肤科医师

葡萄牙

Roxanna SADOUGHIFAR Prof

医师

伊朗

本场演讲内容

小时	讲者	演讲标题	讲稿摘要	数字
10:00	Ehsan KASGARI 医师	Iatrogenic alopecia post aesthetic procedures: Trichoscopic categorization and a novel clinical treatment approach	查看	140684
10:09	Lehavit AKERMAN 医师	Prosthetic hair injection: A novel treatment for androgenetic alopecia - a case series study	查看	140690
10:18	Naeem ASSAF 医师	Hair transplant with micrografting technology	查看	140689
10:27	Nuttorn NARUPAVES 医师	Hair restoration with combination techniques	查看	140686
10:36	Kamal KUMAR 医师	Retrospective assessment of nutritional factors and non-surgical multimodal therapy in non-cicatricial alopecia	查看	140688
10:45	Hind BENHIBA 医师	Injectable platelet-rich fibrin and its results in female pattern hair loss	查看	140691
10:54	Barry DEKEYSER 医师	Systematic approach to diagnosing and treating hair loss: The role of trichoscopy, PRP, and laser therapy	查看	140683
11:03	Mehdi SHIRI 医师	Breast cancer screening in patients with Frontal Fibrosing Alopecia	查看	140687
11:12	Bogdan Morad AL BZOUR 医师	The jungle of hair restoration and mixed therapies	查看	146456
11:21		Q&A		144437

上一个会议室 (Room 143 - Level 1)

进入下一场会议

推荐会议

脱发

毛发移植

联合疗法

生长因子

干细胞

Ehsan KASGARI 医师

医师

伊朗

其他作者 : Ahmad Nazari MD

Iatrogenic alopecia post aesthetic procedures: Trichoscopic categorization and a novel clinical treatment approach

Objectives: The primary objective of this study is to categorize iatrogenic alopecia induced by non-surgical aesthetic procedures based on advanced trichoscopic findings. By delineating specific trichoscopic features, such as variation in follicular ostia, perifollicular discoloration, hair shaft caliber changes, and the presence of dystrophic hairs or cadaverized hairs, we aim to correlate these features with tailored therapeutic strategies. This categorization will aid in precise diagnosis and optimization of treatment approaches, addressing the pathophysiological nuances of each alopecia subtype.

Introduction: Iatrogenic alopecia following non-surgical aesthetic procedures represents a complex and often underappreciated clinical challenge. This study aims to establish a novel categorization system for iatrogenic alopecia, utilizing detailed trichoscopic analysis. Trichoscopy, with its ability to reveal subtle changes in follicular structure, perifollicular patterns, and hair shaft integrity, offers a precise diagnostic tool for differentiating types of alopecia. This categorization not only enhances diagnostic precision but also guides the implementation of targeted therapeutic protocols.

Materials / method: In this retrospective study, we analyzed 28 cases of iatrogenic alopecia subsequent to non-surgical aesthetic interventions. Trichoscopic evaluations were conducted with a focus on identifying distinct features such as: (1) Follicular Miniaturization with decreased hair shaft diameter and reduced terminal
hair ratio, (2) Perifollicular Hyperpigmentation or the presence of Peripilar Signs, indicative of inflammatory processes, (3) Ruptured Hair Shafts with trichorrhexis nodosa-like appearances and flame hairs, and (4) Yellow Dots with perifollicular fibrosis suggestive of chemical panniculitis

Results: four distinct: (1) Reduced Follicular Density and Absence of Terminal Anagen Follicles (21%), often caused by vascular compromise leading to ischemia and increased telogen effluvium; (2) Brittle and Miniaturized Hair with Peripilar Sign (11%), primarily due to chronic inflammation and chemical irritation from mesotherapy or other injectable treatments; (3) Ruptured Hair Shafts with Perifollicular Inflammation (25%), resulting from structural damage due to physical or chemical trauma; and (4) Yellow Dots with Perifollicular Fibrosis (14%), typically following panniculitis from fat-dissolving.

Conclusion: This study presents a novel trichoscopic categorization of iatrogenic alopecia resulting from non-surgical aesthetic procedures, linking each category to its underlying cause and appropriate therapeutic strategy. By using advanced trichoscopic criteria and understanding the etiological mechanisms, clinicians can more accurately diagnose and treat iatrogenic alopecia, resulting in better patient outcomes. This approach represents a significant advancement in the management of alopecia, offering a precision medicine framework tailored to the unique needs of each patient.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Lehavit AKERMAN 医师

皮肤科医师

以色列

其他作者 :

Prosthetic hair injection: A novel treatment for androgenetic alopecia - a case series study

Objectives: A retrospective analysis of the efficacy and safety of prosthetic hair restoration in 20 woman who underwent this procedure on our clinic.

Introduction: Alopecia is a common medical condition affecting both sexes. Androgenetic alopecia is one of the most common conditions and is a stressful experience for both sexes, but substantially more distressing for women. Women with androgenetic alopecia possess a more negative body image and a pattern of less adaptive functioning. Although this is a verry common condition we still lack a non surgical effective treatment and Surgical Restoration remains the only reliable method to restore hair in women. Therefore there is a need for an additional non-surgical treatment option.

Materials / method: 20 patients (ages 45-68) underwent prosthetic hair injection. All patients underwent a test procedure in which 48 hairs were implanted to make sure there is no adverse reaction and 6 weeks later underwent full treatment. Patients underwent between 1-3 treatment sessions with prosthetic hair fibers ( by Hairstetics LTD). Hair implants is made of two biocompatible materials: nitinol and nylon and are preloaded on sterile disposable cartridges 12 hair fibers on each. All patients were injected with 768-1152 at each treatment session. Side effects and patient satisfaction were monitoed.

Results: All patients that were chosen to undergo this treatment had good clinical improvement and over 80% mentioned that it improved their self confidence and body image. Side effects were mostly mild and included focal erythema and papular lesions (in 4 patients overall). No patients needed an extraction of the implants.

Conclusion: Prosthetic hair injection is a safe and effective procedure mainly for woman with stable androgenetic alopecia- since there is a need for a reliable minimally invasive procedure .It can serve as an additional tool for patients which are looking for an office procedure rather a surgical one. Patient selection is crucial for positive outcome.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Naeem ASSAF 医师

皮肤科医师

约旦

其他作者 :

Hair transplant with micrografting technology

Objectives: Very high success rate of transplanted hair when combining with autologous Micrografting technology specifically in the early 48 hours of hair transplant

Introduction: Many people around the world suffer from Androgenetic Alopecia (AGA). There are well-known and approved medications such as Minoxidil and Finasteride, in addition to hair transplant surgery. Recently the use of micrografting technology showed promising results when used for patients with specific ddconditions. There are constraints when it comes to the benefits of using this technology.

Materials / method: Micrografting achieves autologous cell suspension by mechanical fragmentation of subcutaneous and adipose tissue from the occipital area. The use of the safe micrografting technology in the first 48 hr of transplantation surgery can give us high success rate of transplanted hair

Results: High success rate of transplanted hair
Decrease or Stop hair loss for Androgenic alopecia
Thickening of the hair
Regrowing of hair fibers from the viable hair grafts

Conclusion: After treating over 2700 androgenic alopecia patients in my clinic using autologous micrografting technology and by applying a specific treatment protocol for each case; depending of the remaining viable follicles, or with hair transplantation surgey;
Promising results were achieved.
Furthermore, the use of micrografting technology is a treatment for all parts of the head with minimum to null recovery time.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Nuttorn NARUPAVES 医师

医师

泰国

其他作者 : Dr.Nuttorn narupaves

Hair restoration with combination techniques

Objectives: This study aimed to confirm the combination of Follicular Unit Extraction (FUE) and nanofat to enhance the density results in high grade baldness patients

Introduction: Male Androgenetic Alopecia (MAGA) has been one of the most common reasons for consultation. Shaven FUE has been an attractive treatment option for patterns with severe AGA. FUE hair transplant is becoming most wanted with demand for higher density and coverage of baldness. It has evolved mainly with the aim of making the results look more natural with no scar. In high grade of baldness,scalp donor has limit to fulfill the required number of follicles for Norwood grade V and VI baldness. Nanofat can use combine with FUE for stimulate hair growth and prevent shock loss

Materials / method: Fifty male patients with poor density AGA in Hamilton Norwood Grade V-VI were enrolled in the research. All participants underwent one nanofat session and two FUE hair transplantation sessions. Nanofats were inject all scalp areas one month before the first session of FUE hair transplantation. The second session of FUE hair transplants were done after first session 6-9 months. All patients were general conditions. Assessment were evaluated with photography.

Results: Combination is a good result answer to cover higher grades of baldness. We harvested an average of 2500± grafts per session.Recipient density ranged from 40 FUE/cm2 to 50 FUE/cm2.Nanofat can effectively lead to natural density and appearance in one session. Nanofat helps enhance hair growth. The combination of FUE hair transplant and nanofat can improve high grade baldness that a large number of grafts. It can use combine with shaven FUE to cover up frontal and crown area balding.

Conclusion: According to the outcomes, nanofat and shaven FUE is satisfactory treatment for patients with high grade baldness. Nanofat contains abundant stromal vascular fraction cells and adipose-derived stem cells. Adiposed derived stem cells were still richly present in nanofat. It contains angiogenic growth factors and other molegules that can promote the growth of new blood vessels, which are essential for the nourishment of hair follicles. It provides high success rates for hair transplantation. Combined treatment with nanofat and and FUE is more effective than alone.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Kamal KUMAR 医师

整形外科医师

印度

其他作者 :

Retrospective assessment of nutritional factors and non-surgical multimodal therapy in non-cicatricial alopecia

Objectives: The objective of this study is to examine the biochemical, nutritional, and lifestyle contributors to hair loss and evaluate the role of multimodal therapy in managing non-cicatricial alopecia. Specifically,
it aims to:
-Identify metabolic and nutritional deficiencies—such as elevated triglycerides, cholesterol, and deficiencies in Vitamin D3, Vitamin B12, and iron—potentially linked to hair loss, with a focus on gender differences.
-Assess the efficacy of an integrative treatment approach that combines autologous multi-spin PRP, topical minoxidil, oral finasteride, and lifestyle adjustments

Introduction: This study investigates hair loss as a condition influenced by various factors, including genetics, nutrition, and lifestyle, aiming to evaluate both biochemical assessments and the efficacy of multimodal therapy.

Materials / method: Laboratory Analysis:Blood samples from 594 patients were analyzed after an 8-hour fast to assess triglycerides, cholesterol, Vitamin D3, Vitamin B12, and iron levels, exploring metabolic and nutritional contributors to hair loss.
Multimodal Therapy: A subset of 350 patients were selected, classified by Norwood-Hamilton and Ludwig scales, received eight sessions of therapy including PRP, topical minoxidil, and oral finasteride along with nutritional deficiencies corrections (if) required, along with life style modifications to target non-cicatricial alopecia.

Results: Laboratory Findings: High levels of triglycerides and cholesterol were prevalent among male patients, indicating a possible link to hair loss. Vitamin D3, Vitamin B12, and iron deficiencies were common, especially among males, underscoring nutritional factors in hair loss.

Therapy Outcomes: Noticeable improvements in hair density and diameter were achieved in patients with lower-grade alopecia. Advanced cases (Grades 6-7 in males and Grade 3 in females) showed moderate improvement, reflecting mixed patient satisfaction.

Conclusion: Laboratory screening for metabolic and nutritional deficiencies in patients with hair loss is valuable. The effectiveness of multimodal therapy reinforces the importance of a comprehensive approach, combining multiple spinning PRP, pharmacologic, and lifestyle modifications to manage non-cicatricial alopecia.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Hind BENHIBA 医师

皮肤科医师

摩洛哥

其他作者 :

Injectable platelet-rich fibrin and its results in female pattern hair loss

Objectives: Female pattern hair loss (FPHL) is a common form of non-scarring hair and often a source of significant psychological distress. Autologous platelet aggregates have been proposed as a potential therapy to treat FPHL, either alone or in combination treatment. In this study, we aimed to evaluate the application of injectable platelet-rich fibrin (i-PRF) as a novel hair loss solution, with a review of literature data.

Introduction: Various trials have been conducted on the management of female pattern hair loss, but the outcomes often seem to be limited. Platelet-rich plasma (PRP) has a well-established role as adjunctive therapy in androgenetic alopecia but there are many limitations of it. In an attempt to overcome the shortcomings of PRP, liquid platelet-rich fibrin (PRF) is guaranteeing a prolonged release of growth factors and cytokines and a three-dimensional scaffold structure for hair cells regrowth.

Materials / method: 11 patients were enrolled in this scalp trial underwent 4-monthly intradermal injections of i-PRF. Under all aseptic precautions, the tubes were centrifuged at 800 rpm for four minutes. The i-PRF obtained was injected in deep dermal area using point by point and nappage technique. Patients have completed total of 4 sessions, at an interval of one month. Maintenance sessions were proposed 4 times per year. Mean hair count and hair thickness, global assessment by the investigators, subject self-assessment and adverse effects were assessed.

Results: The mean number of hair follicles containing hairs per unit area improved at 3- and 6-months follow-up (p < .001), and all participants had a negative hair pull test. Hair volume and thickness, and patient-reported outcome scores also improved at follow-up (p < .001). Adverse effects were minor and self-limited. A series of three i-PRF injection sessions were effective for the treatment of FPHL, as shown by improved hair analysis parameters (in both V-scalp points and F-scalp points) and patient self-assessment scores.

Conclusion: Injectable platelet rich fibrin (i-PRF) seems to be an effective therapy and safe autologous biomaterial for androgenetic alopecia . To ascertain and potentiate our findings, large scale studies are required.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Barry DEKEYSER 医师

麻醉师

比利时

其他作者 :

Systematic approach to diagnosing and treating hair loss: The role of trichoscopy, PRP, and laser therapy

Objectives: In this presentation, I will provide physicians with a systematic approach to diagnosing and treating common hair disorders, based on my extensive experience as a practitioner, trainer, and advisor in hair conditions. The role of trichoscopy in diagnostics will be highlighted. Several case studies will be presented, where patients were treated with platelet-rich plasma (PRP) and/or Er:YAG laser therapy. PRP and LASER are two modalities that have garnered significant interest from both patients and hair specialists in recent years. For this reason alone, they deserve our attention.

Introduction: Globally, hundreds of millions of men and women are affected by hair loss. Only a minority seek medical help; many choose not to start medical treatment or discontinue it prematurely. Patients often search for solutions online, falling prey to quack remedies that promise miracle cures. Physicians who aim to treat these patients must be prepared to become experts in hair loss. By following a systematic approach—comprising rigorous diagnostics and a selection of scientifically proven treatments —they can guide patients through the complex pathology of various hair conditions.

Materials / method: Using a variety of case studies, diagnostic pathways and biostimulatory treatments will be presented. Trichoscopy allows for the rapid and accurate identification of pathognomonic features of conditions like androgenetic alopecia. The use of artificial intelligence (AI) further provides an accurate overview of the patient’s current hair status. Treatments with PRP and Class 4 Er:YAG laser will be described in detail. The rationale behind therapy selection, the development of specific treatment protocols, and the methods of follow-up and evaluation will be discussed.

Results: The results of these treatments will be thoroughly discussed, supported by standardized before-and-after photographs.

Conclusion: The days when patients had to helplessly watch their hair gradually deteriorate are definitively behind us. For many patients, hair preservation is within reach. Physicians interested in treating these patients must become proficient in the complexities of hair loss, its various entities, and the appropriate treatments. Accurate diagnosis is crucial, and several treatment options have been scientifically researched, although the search for the optimal combination of therapies continues to evolve.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
是
请注明名称（个人，公司，学会等等）: Member LAHA Faculty, Trainer Arthrex, Clinical Expert Fotona Lasers

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Mehdi SHIRI 医师

皮肤科医师

伊朗

其他作者 : Hadi Shiri - Kermanshah university of medical sciences ,Medical School; Behrouz Shiri- - Diar Pharma Tehran Ltd., Clinical Dermatology; Farideh Bahrami - Diar Pharma Tehran Ltd., Dermatosurgery; Saeedeh Shiri-Ferdowsi University of Mashhad ,Genetics

Breast cancer screening in patients with Frontal Fibrosing Alopecia

Objectives: In the patients with FFA, there is no specific report of Breast cancer and its molecular genetic basis. We aimed to investigate the risk of Breast cancer in patients with FFA.

Introduction: Frontal fibrosing alopecia (FFA) is an inflammatory scarring alopecia affecting almost women. It results from the dynamic interaction of genetic, environmental, immunologic and hormonal factors.

Materials / method: We conducted a multicenter case–control study to explore risk factors for FFA and its related comorbidities. The medical records of women with clinicopathologic confirmation of FFA within 2015-2020 and controls from age-matched women were gathered through the data registry. Genetic testing for BRCA1 gene, screening mammography and if required MRI were performed for all the participants.

Results: 300 cases of FFA and 320 age-matched healthy controls (35-74 years) were studied. Women with FFA more likely had impaired fasting blood sugar (IFG, 28.6 vs. 13.4%, OR =3.20, 95% CI: 2.98-5.55), history of anti-TPO positive thyroid diseases (12.3 vs. 3.4%, OR =1.41, 95% CI: 1.07-1.87), the frequency of hysterectomy (3.3 vs. 0.6%, OR 2.14, 95% CI 1.35–3.39), history of benign breast disease (57.3% vs. 26.5%, OR =1.68, 95% CI: 1.19-2.38), the frequency of breast cancer, (4.7 vs. 0.9%, OR=3.40, 95% CI: 1.07–8.54), and BRCA1 mutation carriers (1.7 vs. 0.3%, OR = 2.22, 95% CI: : 1.50-3.282)p < 0.05.

Conclusion: The result of this study supports possible correlation of FFA with Breast cancer. The main benefit will be early screening of patients with FFA at risk of Breast cancer along with the potential for new therapies.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Bogdan Morad AL BZOUR 医师

皮肤科医师

罗马尼亚

其他作者 :

The jungle of hair restoration and mixed therapies

Objectives: The obiective of the studies and presentation is to find out which is suitable for each alopecia stage , the fastest method, more efficient & more longitude follicle lifespan. To choose the best method for each stage to look more natural and more hair follicle to be restored.
How to prevent, stop & delay the advancing in hamilton stages.

Introduction: We present . A number of pacient before therapies , in different hamilton grades (( from grade 1 to grade 6 ))

Materials / method: We present . A number of pacient before therapies , in different hamilton grades (( from grade 1 to grade 6 ))
Each stage is under a mono and a mix therapies
Starting with “ minoxidil, exozomes, svf , hair dust cells& natural hair implant “ in more advanced casses when hair fue implant is excluded because of the donor area or scars we combine it with svf of biocompatible fibres.
The groups are watched under studies for 4 years.
Following the evolution, the success rate the outcoming results, and the longitivity of the results .

Results: - in fibrotic scars svf & exozomes created new microcirculation. After hair dust cells, new hair follcilles are noted and the installed of implanted hair is lore successful .
- grade 1,2,3 of hamilton mostly be restored with minim fue implant, more svf & exozomes sessions .
- svf & hair dust can prevent for a while progressing of alopecia in first grades especially front lines.
- combining svf and micro hair dust with fue requires a smaller donor area to be implanted to achieve a suitable result.Less follicles than fue as a mono therapy.
Biofibre just in certain stages of alopecia is recomand

Conclusion: Svf therapy mixed with natural autologous blood exozomes and hair dus cells are modern therapies that may prevent follicle loose and create new follicles especially hamilton 1,2,3
In hamilton 3 it can boost the regeneration by using fue natural implant but the results are observed more density seen in the treated area.
Ham
The efficiency of svf & exozomes in creating new microc-circulation vessels in the fibrotic areas after fibrotic scars.
The efficiency of biofibre hair compatible method in hamilton 5-6 and in sever fibrotic tissue scalp.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Q&A

距离法国巴黎大会还有

0 1 8

天数至法国巴黎

您有问题要问？

在我们的常见问题解答中快速找到答案

大会

英卡思巴黎国际年会
英卡思美洲年会
英卡思亚洲年会
英卡思中国大会

关于我们

公司
隐私政策
法律信息

学院

主页
课程
Webinars
探索
博客

支援

教育援助

保持联系

联系我们

登录名/电邮地址

密码

保持登录状态

密码遗失 ? 还没有账号？现在注册

保持登录状态

academy.Do_not_have_an_account_yet 现在注册

2025 英卡思巴黎国际年会 大会日程

聚焦

Hair restoration - Contributed talks

主席

本场演讲内容

推荐会议

2025 英卡思巴黎国际年会
大会日程

本场演讲内容